838 related articles for article (PubMed ID: 24140245)
21. Outcomes after urothelial recurrence in bladder cancer patients undergoing radical cystectomy.
Mitra AP; Alemozaffar M; Harris BN; Schuckman AK; Skinner EC; Daneshmand S
Urology; 2014 Dec; 84(6):1420-6. PubMed ID: 25306479
[TBL] [Abstract][Full Text] [Related]
22. Comparative performance of comorbidity indices for estimating perioperative and 5-year all cause mortality following radical cystectomy for bladder cancer.
Boorjian SA; Kim SP; Tollefson MK; Carrasco A; Cheville JC; Thompson RH; Thapa P; Frank I
J Urol; 2013 Jul; 190(1):55-60. PubMed ID: 23313198
[TBL] [Abstract][Full Text] [Related]
23. Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy.
Tilki D; Shariat SF; Lotan Y; Rink M; Karakiewicz PI; Schoenberg MP; Lerner SP; Sonpavde G; Sagalowsky AI; Gupta A
BJU Int; 2013 Jun; 111(8):1215-21. PubMed ID: 23181623
[TBL] [Abstract][Full Text] [Related]
24. Oncologic outcomes for lymph node-positive urothelial carcinoma patients treated with robot assisted radical cystectomy: with mean follow-up of 3.5 years.
Mmeje CO; Nunez-Nateras R; Nielsen ME; Pruthi RS; Smith A; Wallen EM; Humphreys MR; Woods ME; Castle EP
Urol Oncol; 2013 Nov; 31(8):1621-7. PubMed ID: 22534088
[TBL] [Abstract][Full Text] [Related]
25. Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder.
Rogers CG; Palapattu GS; Shariat SF; Karakiewicz PI; Bastian PJ; Lotan Y; Gupta A; Vazina A; Gilad A; Sagalowsky AI; Lerner SP; Schoenberg MP
J Urol; 2006 Jun; 175(6):2048-53; discussion 2053. PubMed ID: 16697800
[TBL] [Abstract][Full Text] [Related]
26. Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection.
Sternberg IA; Keren Paz GE; Chen LY; Herr HW; Dalbagni G
BJU Int; 2013 Jul; 112(1):54-9. PubMed ID: 23146082
[TBL] [Abstract][Full Text] [Related]
27. Intermediate-term oncologic outcomes of robot-assisted radical cystectomy for urothelial carcinoma.
Yuh B; Torrey RR; Ruel NH; Wittig K; Tobis S; Linehan J; Lau CS; Chan KG; Yamzon J; Wilson TG
J Endourol; 2014 Aug; 28(8):939-45. PubMed ID: 24635448
[TBL] [Abstract][Full Text] [Related]
28. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
29. Multifactorial, site-specific recurrence model after radical cystectomy for urothelial carcinoma.
Umbreit EC; Crispen PL; Shimko MS; Farmer SA; Blute ML; Frank I
Cancer; 2010 Jul; 116(14):3399-407. PubMed ID: 20564121
[TBL] [Abstract][Full Text] [Related]
30. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
[TBL] [Abstract][Full Text] [Related]
31. Impact of body mass index on the oncological outcomes of patients treated with radical cystectomy for muscle-invasive bladder cancer.
Dabi Y; Rouscoff Y; Anract J; Delongchamps NB; Sibony M; Saighi D; Zerbib M; Peyraumore M; Xylinas E
World J Urol; 2017 Feb; 35(2):229-235. PubMed ID: 27272203
[TBL] [Abstract][Full Text] [Related]
32. Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients.
Tilki D; Reich O; Svatek RS; Karakiewicz PI; Kassouf W; Novara G; Ficarra V; Chade DC; Fritsche HM; Gerwens N; Izawa JI; Lerner SP; Schoenberg M; Stief CG; Skinner E; Lotan Y; Sagalowsky AI; Shariat SF
J Urol; 2010 May; 183(5):1757-63. PubMed ID: 20299059
[TBL] [Abstract][Full Text] [Related]
33. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.
Viers BR; Boorjian SA; Frank I; Tarrell RF; Thapa P; Karnes RJ; Thompson RH; Tollefson MK
Eur Urol; 2014 Dec; 66(6):1157-64. PubMed ID: 24630414
[TBL] [Abstract][Full Text] [Related]
34. Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making.
Aziz A; Shariat SF; Roghmann F; Brookman-May S; Stief CG; Rink M; Chun FK; Fisch M; Novotny V; Froehner M; Wirth MP; Schnabel MJ; Fritsche HM; Burger M; Pycha A; Brisuda A; Babjuk M; Vallo S; Haferkamp A; Roigas J; Noldus J; Stredele R; Volkmer B; Bastian PJ; Xylinas E; May M
BJU Int; 2016 Feb; 117(2):272-9. PubMed ID: 25381844
[TBL] [Abstract][Full Text] [Related]
35. Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes.
Ma B; Li H; Zhang C; Yang K; Qiao B; Zhang Z; Xu Y
Eur J Surg Oncol; 2013 Oct; 39(10):1150-6. PubMed ID: 23721764
[TBL] [Abstract][Full Text] [Related]
36. Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy.
Rink M; Hansen J; Cha EK; Green DA; Babjuk M; Svatek RS; Xylinas E; Tagawa ST; Faison T; Novara G; Karakiewicz PI; Daneshmand S; Lotan Y; Kassouf W; Fritsche HM; Pycha A; Comploj E; Tilki D; Bastian PJ; Chun FK; Dahlem R; Scherr DS; Shariat SF
BJU Int; 2013 Jan; 111(1):74-84. PubMed ID: 22809039
[TBL] [Abstract][Full Text] [Related]
37. The impact of variant histological differentiation on extranodal extension and survival in node positive bladder cancer treated with radical cystectomy.
Marks P; Gild P; Soave A; Janisch F; Minner S; Engel O; Vetterlein MW; Shariat SF; Sauter G; Dahlem R; Fisch M; Rink M
Surg Oncol; 2019 Mar; 28():208-213. PubMed ID: 30851902
[TBL] [Abstract][Full Text] [Related]
38. Age ≥ 80 years is independently associated with survival outcomes after radical cystectomy: results from the Canadian Bladder Cancer Network Database.
Fairey AS; Kassouf W; Aprikian AG; Chin JL; Izawa JI; Fradet Y; Lacombe L; Rendon RA; Bell D; Cagiannos I; Drachenberg DE; Lattouf JB; Estey EP
Urol Oncol; 2012; 30(6):825-32. PubMed ID: 21889368
[TBL] [Abstract][Full Text] [Related]
39. Differential effect on survival of pelvic lymph node dissection at radical cystectomy for muscle invasive bladder cancer.
Larcher A; Sun M; Schiffmann J; Tian Z; Shariat SF; McCormack M; Saad F; Fossati N; Abdollah F; Briganti A; Buffi N; Graefen M; Guazzoni G; Montorsi F; Karakiewicz PI
Eur J Surg Oncol; 2015 Mar; 41(3):353-60. PubMed ID: 25477269
[TBL] [Abstract][Full Text] [Related]
40. The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma.
Kim SP; Frank I; Cheville JC; Thompson RH; Weight CJ; Thapa P; Boorjian SA
J Urol; 2012 Aug; 188(2):405-9. PubMed ID: 22704101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]